Thesis
NVO is attempting a structural reversal after a deep corrective phase, supported by both long-term trend support and improving fundamental visibility.
Context
- Weekly timeframe
- 70% correction from cycle highs
- Price has respected the long-term trendline originating in 2016
- Recent product developments in weight-loss therapies improve long-term business outlook
What I see
- Price held the long-term rising support after the correction
- Recent advance reclaimed the 50-day moving average
- Price is consolidating above short-term support, suggesting stabilization
- Structure is transitioning from decline to base formation
What matters now
- Holding above the 50-day MA keeps the early reversal structure intact
- Next key test sits at the confluence of the 0.618 Fibonacci retracement and the 200-day moving average near the $60 area
Buy / Accumulation zone
- Pullbacks toward the current base and rising support zone remain the area of interest
Targets
- Initial resistance at the 0.618 Fib / 200-day MA confluence
- A confirmed higher low after that test would define Wave 1–2 structure
- Longer-term reference remains the 200-week moving average overhead
Risk / Invalidation
- Loss of the long-term trendline would invalidate the reversal thesis
NVO is attempting a structural reversal after a deep corrective phase, supported by both long-term trend support and improving fundamental visibility.
Context
- Weekly timeframe
- 70% correction from cycle highs
- Price has respected the long-term trendline originating in 2016
- Recent product developments in weight-loss therapies improve long-term business outlook
What I see
- Price held the long-term rising support after the correction
- Recent advance reclaimed the 50-day moving average
- Price is consolidating above short-term support, suggesting stabilization
- Structure is transitioning from decline to base formation
What matters now
- Holding above the 50-day MA keeps the early reversal structure intact
- Next key test sits at the confluence of the 0.618 Fibonacci retracement and the 200-day moving average near the $60 area
Buy / Accumulation zone
- Pullbacks toward the current base and rising support zone remain the area of interest
Targets
- Initial resistance at the 0.618 Fib / 200-day MA confluence
- A confirmed higher low after that test would define Wave 1–2 structure
- Longer-term reference remains the 200-week moving average overhead
Risk / Invalidation
- Loss of the long-term trendline would invalidate the reversal thesis
Long term investor. Open portfolio and full thesis on eToro: etoro.com/people/maratteo
免責事項
これらの情報および投稿は、TradingViewが提供または承認する金融、投資、取引、またはその他の種類の助言もしくは推奨であることを意図したものではなく、またこれらに該当するものでもありません。詳細は利用規約をご覧ください。
Long term investor. Open portfolio and full thesis on eToro: etoro.com/people/maratteo
免責事項
これらの情報および投稿は、TradingViewが提供または承認する金融、投資、取引、またはその他の種類の助言もしくは推奨であることを意図したものではなく、またこれらに該当するものでもありません。詳細は利用規約をご覧ください。